Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 45Observational 1

Sponsor

Cancer Type

CNS 1

Conditions

Breast Neoplasms 694Neoplasms 612Prostatic Neoplasms 315Lung Neoplasms 308Colorectal Neoplasms 280Carcinoma, Non-Small-Cell Lung 254Pancreatic Neoplasms 178Carcinoma, Hepatocellular 168Stomach Neoplasms 139Multiple Myeloma 127Ovarian Neoplasms 120Melanoma 118Colonic Neoplasms 112Brain Neoplasms 108Hematologic Neoplasms 107Head and Neck Neoplasms 106Urinary Bladder Neoplasms 103Leukemia, Myeloid, Acute 102Esophageal Neoplasms 101Disease 100Uterine Cervical Neoplasms 88Neoplasm Metastasis 88Liver Neoplasms 88Rectal Neoplasms 85Lymphoma 84Precursor Cell Lymphoblastic Leukemia-Lymphoma 83Endometrial Neoplasms 76Carcinoma, Renal Cell 73Leukemia 63Recurrence 62

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Meningeal Carcinomatosis × 1 year × Clear all
NCT07239102 2025-11-20

Firmonertinib in the Treatment of EGFR(+) NSCLC Patients With Central Nervous System Metastasis

Beijing Tiantan Hospital

Completed
300 enrolled
CNS

Meningeal Carcinomatosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡